Suppr超能文献

表观扩散系数预测局部晚期直肠癌放化疗疗效的有效性:一项系统评价和荟萃分析

Effectiveness of the apparent diffusion coefficient for predicting the response to chemoradiation therapy in locally advanced rectal cancer: a systematic review and meta-analysis.

作者信息

Xie Haiting, Sun Tao, Chen Ming, Wang Hao, Zhou Xin, Zhang Yunkai, Zeng Huanhong, Wang Jilian, Fu Wei

机构信息

From the Department of General Surgery (MX, TS, XZ, YZ, HZ, JW, WF), Peking University Third Hospital; Department of Radiology (MC), Peking University Third Hospital; and Department of Radiation Oncology (HW), Peking University Third Hospital, Beijing, China.

出版信息

Medicine (Baltimore). 2015 Feb;94(6):e517. doi: 10.1097/MD.0000000000000517.

Abstract

The efficacy of the different apparent diffusion coefficients (ADCs) in predicting different responses to preoperative chemoradiation therapy (CRT) in patients with locally advanced rectal cancer (LARC) is controversial. We did this meta-analysis to evaluate the efficacy of different ADCs predicting different responses to CRT in patients with LARC.We systematically searched the MEDLINE, Embase, and Cochrane Library databases for articles published from January 1, 1990, to June 3, 2014. Pooled estimates were calculated using a bivariate random-effects model for the ADCs before and after CRT (pre- and post-ADC), as well as the change between the pre- and post-ADC (ΔADC). The values of the 3 ADCs for judging different response endpoints, which were defined according to the tumor grading (TRG) system and downstaging of T (tumor) or N (nodal) stages (TN downstaging), were assessed.We included 16 studies with a total of 826 patients. The sensitivity, specificity, DOR, and AUC were 75% (95% CI 57%-87%), 70% (95% CI 50%-84%), 6.81 (95% CI 2.46-18.88), and 0.79 (95% CI 0.75-0.82), respectively, for the pre-ADC in predicting a good response; 76% (95% CI 63%-85%), 87% (95% CI 78%-92%), 20.68 (95% CI 11.76-36.39), and 0.89 (95% CI 0.86-0.91), respectively, for the post-ADC; and 78% (95% CI 65%-87%), 77% (95% CI 62%-87%), 11.82 (95% CI 4.65-30.04), and 0.84 (95% CI 0.81-0.87), respectively, for the ΔADC. The post-ADC demonstrated the highest specificity and DOR (P < 0.001), although sensitivity did not differ between the 3 types of ADC (P = 0.380, 0.192, and 0.214). For predicting a pathological complete response (pCR), the post-ADC had the highest specificity (P < 0.001and 0.030) but lowest sensitivity (P < 0.001). The ΔADC had the highest DOR; however, this difference was not statistically significant (P = 0.146).The ADC is a reliable and reproducible measure and could serve as a promising noninvasive tool for evaluating the response to CRT in patients with LARC; the post-ADC and ΔADC are particularly promising. The ΔADC had the highest diagnostic performance to predict a pCR compared with the pre-ADC and post-ADC. The value of the ADCs to predict T or N downstaging requires further investigation.

摘要

不同表观扩散系数(ADC)在预测局部晚期直肠癌(LARC)患者术前放化疗(CRT)不同反应中的疗效存在争议。我们进行这项荟萃分析以评估不同ADC预测LARC患者对CRT不同反应的疗效。我们系统检索了MEDLINE、Embase和Cochrane图书馆数据库中1990年1月1日至2014年6月3日发表的文章。使用双变量随机效应模型计算CRT前后ADC(术前和术后ADC)以及术前和术后ADC之间的变化(ΔADC)的合并估计值。评估了根据肿瘤分级(TRG)系统以及T(肿瘤)或N(淋巴结)分期的降期(TN降期)定义的用于判断不同反应终点的3个ADC值。

我们纳入了16项研究,共826例患者。术前ADC预测良好反应的敏感性、特异性、诊断比值比(DOR)和曲线下面积(AUC)分别为75%(95%可信区间57%-87%)、70%(95%可信区间50%-84%)、6.81(95%可信区间2.46-18.88)和0.79(95%可信区间0.75-0.82);术后ADC分别为76%(95%可信区间63%-85%)、87%(95%可信区间78%-92%)、20.68(95%可信区间11.76-36.39)和0.89(95%可信区间0.86-0.91);ΔADC分别为78%(95%可信区间65%-87%)、77%(95%可信区间62%-87%)、11.82(95%可信区间4.65-30.04)和0.84(95%可信区间0.81-0.87)。术后ADC显示出最高的特异性和DOR(P<0.001),尽管3种类型的ADC之间敏感性无差异(P = 0.380、0.192和0.214)。对于预测病理完全缓解(pCR),术后ADC具有最高的特异性(P<0.001和0.030)但最低的敏感性(P<0.001)。ΔADC具有最高的DOR;然而,这种差异无统计学意义(P = 0.146)。

ADC是一种可靠且可重复的测量方法,可作为评估LARC患者对CRT反应的有前景的非侵入性工具;术后ADC和ΔADC尤其有前景。与术前ADC和术后ADC相比,ΔADC预测pCR的诊断性能最高。ADC预测T或N降期的价值需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c5/4602762/aa775ab8f4af/medi-94-e517-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验